Thursday, May 14, 2026

Top 5 This Week

Related Posts

India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Spread the love

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles